TY - JOUR
T1 - ICU-acquired central line-associated bloodstream infection and its associated factors in Oman
AU - AL-Shukri, Rehab Nasser
AU - AL-Rawajfah, Omar M.
AU - Al-Daken, Liala
AU - Al-Busaidi, Mujahid
N1 - Publisher Copyright:
© 2022 Association for Professionals in Infection Control and Epidemiology, Inc.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - BACKGROUND: Despite the extensive use of central lines for ICU patients in Oman, no studies have been conducted among adult ICU patients to assess the prevalence, and predictors of CLABSIs.AIM: To estimate the prevalence of ICU-acquired CLABSIs, identify the most common causative microorganisms, and define possible related risk factors associated with ICU-acquired CLABSIs among adult ICU patients in Oman.METHOD: A retrospective case-control design was used to screen electronic medical records of for all adult ICU patients admitted over 2 years (2018-2019) in 2 tertiary hospitals in Oman. The CDC definition of CLABSIs was used to allocate a cases group (n = 58), and a randomly selected controls group (n = 174).RESULTS: The prevalence of ICU-acquired CLABSIs was 8.9 and 8.31 per 1,000 catheter days for the years 2018 and 2019 respectively. The most common isolated microorganisms were gram-positive bacteria (46.6%). The risk factors for ICU-acquired CLABSIs are: heart failure (Odds Ratio [OR] = 11.67, P < .001), female gender (OR = 0.352, P = .035), presence of other infections (OR = 3.4, P = .009), tracheostomy (OR = 5.34, P = .004), and Total Parenteral Nutrition (OR = 3.469, P = .020).CONCLUSIONS: The prevalence of ICU-acquired CLABSIs in developing countries like Oman is higher than most of developed countries. The current study provides baseline data that can be used as a reference for future national studies and help in building strategies to prevent and control ICU-acquired CLABSIs.
AB - BACKGROUND: Despite the extensive use of central lines for ICU patients in Oman, no studies have been conducted among adult ICU patients to assess the prevalence, and predictors of CLABSIs.AIM: To estimate the prevalence of ICU-acquired CLABSIs, identify the most common causative microorganisms, and define possible related risk factors associated with ICU-acquired CLABSIs among adult ICU patients in Oman.METHOD: A retrospective case-control design was used to screen electronic medical records of for all adult ICU patients admitted over 2 years (2018-2019) in 2 tertiary hospitals in Oman. The CDC definition of CLABSIs was used to allocate a cases group (n = 58), and a randomly selected controls group (n = 174).RESULTS: The prevalence of ICU-acquired CLABSIs was 8.9 and 8.31 per 1,000 catheter days for the years 2018 and 2019 respectively. The most common isolated microorganisms were gram-positive bacteria (46.6%). The risk factors for ICU-acquired CLABSIs are: heart failure (Odds Ratio [OR] = 11.67, P < .001), female gender (OR = 0.352, P = .035), presence of other infections (OR = 3.4, P = .009), tracheostomy (OR = 5.34, P = .004), and Total Parenteral Nutrition (OR = 3.469, P = .020).CONCLUSIONS: The prevalence of ICU-acquired CLABSIs in developing countries like Oman is higher than most of developed countries. The current study provides baseline data that can be used as a reference for future national studies and help in building strategies to prevent and control ICU-acquired CLABSIs.
KW - Catheter associated bloodstream infection
KW - ICU-acquired bloodstream infection
KW - Nosocomial bloodstream infection
KW - Intensive Care Units
KW - Cross Infection/etiology
KW - Humans
KW - Case-Control Studies
KW - Oman/epidemiology
KW - Sepsis/epidemiology
KW - Catheterization, Central Venous/adverse effects
KW - Adult
KW - Female
KW - Retrospective Studies
KW - Catheter-Related Infections/prevention & control
UR - http://www.scopus.com/inward/record.url?scp=85123632063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123632063&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/5fe21e2f-6d78-365a-b8d3-9e4bb287a59b/
U2 - 10.1016/j.ajic.2021.12.024
DO - 10.1016/j.ajic.2021.12.024
M3 - Article
C2 - 34986391
AN - SCOPUS:85123632063
SN - 0196-6553
VL - 50
SP - 1026
EP - 1031
JO - American Journal of Infection Control
JF - American Journal of Infection Control
IS - 9
ER -